nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—NR3C1—hematologic cancer	0.112	1	CbGaD
Flunisolide—Betamethasone—hematologic cancer	0.0725	0.208	CrCtD
Flunisolide—Dexamethasone—hematologic cancer	0.0725	0.208	CrCtD
Flunisolide—Triamcinolone—hematologic cancer	0.0708	0.203	CrCtD
Flunisolide—Prednisone—hematologic cancer	0.0672	0.193	CrCtD
Flunisolide—Prednisolone—hematologic cancer	0.0656	0.188	CrCtD
Flunisolide—SERPINA6—Triamcinolone—hematologic cancer	0.0328	0.171	CbGbCtD
Flunisolide—SERPINA6—Prednisolone—hematologic cancer	0.0278	0.145	CbGbCtD
Flunisolide—NR3C1—Triamcinolone—hematologic cancer	0.0153	0.08	CbGbCtD
Flunisolide—NR3C1—Betamethasone—hematologic cancer	0.0132	0.0686	CbGbCtD
Flunisolide—NR3C1—Prednisolone—hematologic cancer	0.013	0.0677	CbGbCtD
Flunisolide—NR3C1—Prednisone—hematologic cancer	0.0123	0.064	CbGbCtD
Flunisolide—NR3C1—Dexamethasone—hematologic cancer	0.00766	0.0399	CbGbCtD
Flunisolide—CYP3A4—Bexarotene—hematologic cancer	0.00578	0.0302	CbGbCtD
Flunisolide—CYP3A4—Lomustine—hematologic cancer	0.00538	0.028	CbGbCtD
Flunisolide—CYP3A4—Busulfan—hematologic cancer	0.00538	0.028	CbGbCtD
Flunisolide—CYP3A4—Thiotepa—hematologic cancer	0.00479	0.025	CbGbCtD
Flunisolide—CYP3A4—Methoxsalen—hematologic cancer	0.00373	0.0194	CbGbCtD
Flunisolide—CYP3A4—Bortezomib—hematologic cancer	0.00355	0.0185	CbGbCtD
Flunisolide—CYP3A4—Daunorubicin—hematologic cancer	0.00339	0.0177	CbGbCtD
Flunisolide—CYP3A4—Cytarabine—hematologic cancer	0.00299	0.0156	CbGbCtD
Flunisolide—CYP3A4—Teniposide—hematologic cancer	0.00295	0.0154	CbGbCtD
Flunisolide—CYP3A4—Ifosfamide—hematologic cancer	0.00272	0.0142	CbGbCtD
Flunisolide—Fluticasone furoate—Betamethasone—hematologic cancer	0.00268	0.0106	CrCrCtD
Flunisolide—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00268	0.0106	CrCrCtD
Flunisolide—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00262	0.0104	CrCrCtD
Flunisolide—CYP3A4—Imatinib—hematologic cancer	0.0026	0.0135	CbGbCtD
Flunisolide—Ciclesonide—Prednisone—hematologic cancer	0.00258	0.0102	CrCrCtD
Flunisolide—Ciclesonide—Prednisolone—hematologic cancer	0.00252	0.00998	CrCrCtD
Flunisolide—Flurandrenolide—Dexamethasone—hematologic cancer	0.00249	0.00986	CrCrCtD
Flunisolide—Flurandrenolide—Betamethasone—hematologic cancer	0.00249	0.00986	CrCrCtD
Flunisolide—CYP3A4—Ruxolitinib—hematologic cancer	0.00245	0.0128	CbGbCtD
Flunisolide—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00241	0.00953	CrCrCtD
Flunisolide—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00241	0.00953	CrCrCtD
Flunisolide—CYP3A4—Nilotinib—hematologic cancer	0.00236	0.0123	CbGbCtD
Flunisolide—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00235	0.00931	CrCrCtD
Flunisolide—CYP3A4—Vinorelbine—hematologic cancer	0.00234	0.0122	CbGbCtD
Flunisolide—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00233	0.00922	CrCrCtD
Flunisolide—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00233	0.00922	CrCrCtD
Flunisolide—Difluprednate—Betamethasone—hematologic cancer	0.00233	0.00922	CrCrCtD
Flunisolide—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00233	0.00922	CrCrCtD
Flunisolide—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00233	0.00922	CrCrCtD
Flunisolide—Difluprednate—Dexamethasone—hematologic cancer	0.00233	0.00922	CrCrCtD
Flunisolide—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00228	0.00901	CrCrCtD
Flunisolide—Difluprednate—Triamcinolone—hematologic cancer	0.00228	0.00901	CrCrCtD
Flunisolide—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00228	0.00901	CrCrCtD
Flunisolide—Flurandrenolide—Prednisolone—hematologic cancer	0.00226	0.00892	CrCrCtD
Flunisolide—Prednicarbate—Dexamethasone—hematologic cancer	0.00219	0.00867	CrCrCtD
Flunisolide—Prednicarbate—Betamethasone—hematologic cancer	0.00219	0.00867	CrCrCtD
Flunisolide—Fluocinonide—Dexamethasone—hematologic cancer	0.00219	0.00867	CrCrCtD
Flunisolide—Fluocinonide—Betamethasone—hematologic cancer	0.00219	0.00867	CrCrCtD
Flunisolide—Clocortolone—Betamethasone—hematologic cancer	0.00219	0.00867	CrCrCtD
Flunisolide—Clocortolone—Dexamethasone—hematologic cancer	0.00219	0.00867	CrCrCtD
Flunisolide—Fluocinonide—Triamcinolone—hematologic cancer	0.00214	0.00847	CrCrCtD
Flunisolide—Prednicarbate—Triamcinolone—hematologic cancer	0.00214	0.00847	CrCrCtD
Flunisolide—Clocortolone—Triamcinolone—hematologic cancer	0.00214	0.00847	CrCrCtD
Flunisolide—CYP3A4—Triamcinolone—hematologic cancer	0.00214	0.0112	CbGbCtD
Flunisolide—Fluocortolone—Betamethasone—hematologic cancer	0.00213	0.00842	CrCrCtD
Flunisolide—Fluocortolone—Dexamethasone—hematologic cancer	0.00213	0.00842	CrCrCtD
Flunisolide—CYP3A4—Dasatinib—hematologic cancer	0.00209	0.0109	CbGbCtD
Flunisolide—Fluocortolone—Triamcinolone—hematologic cancer	0.00208	0.00823	CrCrCtD
Flunisolide—Alclometasone—Betamethasone—hematologic cancer	0.00207	0.00819	CrCrCtD
Flunisolide—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00207	0.00819	CrCrCtD
Flunisolide—Alclometasone—Dexamethasone—hematologic cancer	0.00207	0.00819	CrCrCtD
Flunisolide—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00207	0.00819	CrCrCtD
Flunisolide—CYP3A4—Mitoxantrone—hematologic cancer	0.00206	0.0107	CbGbCtD
Flunisolide—Prednicarbate—Prednisone—hematologic cancer	0.00203	0.00804	CrCrCtD
Flunisolide—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00202	0.008	CrCrCtD
Flunisolide—Alclometasone—Triamcinolone—hematologic cancer	0.00202	0.008	CrCrCtD
Flunisolide—Amcinonide—Dexamethasone—hematologic cancer	0.00202	0.00797	CrCrCtD
Flunisolide—Budesonide—Dexamethasone—hematologic cancer	0.00202	0.00797	CrCrCtD
Flunisolide—Budesonide—Betamethasone—hematologic cancer	0.00202	0.00797	CrCrCtD
Flunisolide—Amcinonide—Betamethasone—hematologic cancer	0.00202	0.00797	CrCrCtD
Flunisolide—Prednicarbate—Prednisolone—hematologic cancer	0.00198	0.00785	CrCrCtD
Flunisolide—Clocortolone—Prednisolone—hematologic cancer	0.00198	0.00785	CrCrCtD
Flunisolide—Fluocortolone—Prednisone—hematologic cancer	0.00197	0.00781	CrCrCtD
Flunisolide—Amcinonide—Triamcinolone—hematologic cancer	0.00197	0.00779	CrCrCtD
Flunisolide—Budesonide—Triamcinolone—hematologic cancer	0.00197	0.00779	CrCrCtD
Flunisolide—Prednisone—Betamethasone—hematologic cancer	0.00196	0.00776	CrCrCtD
Flunisolide—Desonide—Dexamethasone—hematologic cancer	0.00196	0.00776	CrCrCtD
Flunisolide—Desonide—Betamethasone—hematologic cancer	0.00196	0.00776	CrCrCtD
Flunisolide—Diflorasone—Betamethasone—hematologic cancer	0.00196	0.00776	CrCrCtD
Flunisolide—Prednisone—Dexamethasone—hematologic cancer	0.00196	0.00776	CrCrCtD
Flunisolide—Diflorasone—Dexamethasone—hematologic cancer	0.00196	0.00776	CrCrCtD
Flunisolide—Fluocortolone—Prednisolone—hematologic cancer	0.00193	0.00762	CrCrCtD
Flunisolide—Alclometasone—Prednisone—hematologic cancer	0.00192	0.00759	CrCrCtD
Flunisolide—Prednisone—Triamcinolone—hematologic cancer	0.00192	0.00759	CrCrCtD
Flunisolide—Diflorasone—Triamcinolone—hematologic cancer	0.00192	0.00759	CrCrCtD
Flunisolide—Desonide—Triamcinolone—hematologic cancer	0.00192	0.00759	CrCrCtD
Flunisolide—Paramethasone—Dexamethasone—hematologic cancer	0.00191	0.00757	CrCrCtD
Flunisolide—Paramethasone—Betamethasone—hematologic cancer	0.00191	0.00757	CrCrCtD
Flunisolide—Alclometasone—Prednisolone—hematologic cancer	0.00187	0.00741	CrCrCtD
Flunisolide—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00187	0.00741	CrCrCtD
Flunisolide—Paramethasone—Triamcinolone—hematologic cancer	0.00187	0.0074	CrCrCtD
Flunisolide—Amcinonide—Prednisone—hematologic cancer	0.00187	0.00739	CrCrCtD
Flunisolide—Budesonide—Prednisone—hematologic cancer	0.00187	0.00739	CrCrCtD
Flunisolide—Desoximetasone—Betamethasone—hematologic cancer	0.00187	0.00739	CrCrCtD
Flunisolide—Desoximetasone—Dexamethasone—hematologic cancer	0.00187	0.00739	CrCrCtD
Flunisolide—CYP3A4—Betamethasone—hematologic cancer	0.00184	0.00958	CbGbCtD
Flunisolide—Desoximetasone—Triamcinolone—hematologic cancer	0.00182	0.00722	CrCrCtD
Flunisolide—Amcinonide—Prednisolone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Budesonide—Prednisolone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Triamcinolone—Betamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Fluorometholone—Betamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Triamcinolone—Dexamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Mometasone—Dexamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Mometasone—Betamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Loteprednol—Dexamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Loteprednol—Betamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Fluorometholone—Dexamethasone—hematologic cancer	0.00182	0.00721	CrCrCtD
Flunisolide—Diflorasone—Prednisone—hematologic cancer	0.00182	0.0072	CrCrCtD
Flunisolide—Desonide—Prednisone—hematologic cancer	0.00182	0.0072	CrCrCtD
Flunisolide—CYP3A4—Prednisolone—hematologic cancer	0.00181	0.00945	CbGbCtD
Flunisolide—Rimexolone—Betamethasone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Betamethasone—Dexamethasone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Dexamethasone—Betamethasone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Rimexolone—Dexamethasone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Mometasone—Triamcinolone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Loteprednol—Triamcinolone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Fluorometholone—Triamcinolone—hematologic cancer	0.00178	0.00705	CrCrCtD
Flunisolide—Desonide—Prednisolone—hematologic cancer	0.00178	0.00703	CrCrCtD
Flunisolide—Prednisone—Prednisolone—hematologic cancer	0.00178	0.00703	CrCrCtD
Flunisolide—Diflorasone—Prednisolone—hematologic cancer	0.00178	0.00703	CrCrCtD
Flunisolide—Paramethasone—Prednisone—hematologic cancer	0.00177	0.00702	CrCrCtD
Flunisolide—Betamethasone—Triamcinolone—hematologic cancer	0.00174	0.00688	CrCrCtD
Flunisolide—Dexamethasone—Triamcinolone—hematologic cancer	0.00174	0.00688	CrCrCtD
Flunisolide—Rimexolone—Triamcinolone—hematologic cancer	0.00174	0.00688	CrCrCtD
Flunisolide—Paramethasone—Prednisolone—hematologic cancer	0.00173	0.00685	CrCrCtD
Flunisolide—Desoximetasone—Prednisone—hematologic cancer	0.00173	0.00685	CrCrCtD
Flunisolide—CYP3A4—Prednisone—hematologic cancer	0.00171	0.00892	CbGbCtD
Flunisolide—Methylprednisolone—Dexamethasone—hematologic cancer	0.0017	0.00674	CrCrCtD
Flunisolide—Methylprednisolone—Betamethasone—hematologic cancer	0.0017	0.00674	CrCrCtD
Flunisolide—Mometasone—Prednisone—hematologic cancer	0.00169	0.00669	CrCrCtD
Flunisolide—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00169	0.00669	CrCrCtD
Flunisolide—Loteprednol—Prednisone—hematologic cancer	0.00169	0.00669	CrCrCtD
Flunisolide—Fluorometholone—Prednisone—hematologic cancer	0.00169	0.00669	CrCrCtD
Flunisolide—Triamcinolone—Prednisone—hematologic cancer	0.00169	0.00669	CrCrCtD
Flunisolide—Desoximetasone—Prednisolone—hematologic cancer	0.00169	0.00668	CrCrCtD
Flunisolide—Prednisolone—Betamethasone—hematologic cancer	0.00167	0.0066	CrCrCtD
Flunisolide—Prednisolone—Dexamethasone—hematologic cancer	0.00167	0.0066	CrCrCtD
Flunisolide—Methylprednisolone—Triamcinolone—hematologic cancer	0.00166	0.00659	CrCrCtD
Flunisolide—Betamethasone—Prednisone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Dexamethasone—Prednisone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Rimexolone—Prednisone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Loteprednol—Prednisolone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Triamcinolone—Prednisolone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Mometasone—Prednisolone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Fluorometholone—Prednisolone—hematologic cancer	0.00165	0.00653	CrCrCtD
Flunisolide—Prednisolone—Triamcinolone—hematologic cancer	0.00163	0.00645	CrCrCtD
Flunisolide—CYP3A4—Irinotecan—hematologic cancer	0.00162	0.00846	CbGbCtD
Flunisolide—Rimexolone—Prednisolone—hematologic cancer	0.00161	0.00638	CrCrCtD
Flunisolide—Betamethasone—Prednisolone—hematologic cancer	0.00161	0.00638	CrCrCtD
Flunisolide—Dexamethasone—Prednisolone—hematologic cancer	0.00161	0.00638	CrCrCtD
Flunisolide—Hydrocortisone—Betamethasone—hematologic cancer	0.0016	0.00633	CrCrCtD
Flunisolide—Hydrocortisone—Dexamethasone—hematologic cancer	0.0016	0.00633	CrCrCtD
Flunisolide—Methylprednisolone—Prednisone—hematologic cancer	0.00158	0.00625	CrCrCtD
Flunisolide—Hydrocortisone—Triamcinolone—hematologic cancer	0.00156	0.00619	CrCrCtD
Flunisolide—Prednisolone—Prednisone—hematologic cancer	0.00155	0.00612	CrCrCtD
Flunisolide—Methylprednisolone—Prednisolone—hematologic cancer	0.00154	0.0061	CrCrCtD
Flunisolide—Hydrocortisone—Prednisone—hematologic cancer	0.00148	0.00587	CrCrCtD
Flunisolide—Hydrocortisone—Prednisolone—hematologic cancer	0.00145	0.00573	CrCrCtD
Flunisolide—CYP3A4—Vinblastine—hematologic cancer	0.00144	0.00752	CbGbCtD
Flunisolide—CYP3A4—Vincristine—hematologic cancer	0.00142	0.00739	CbGbCtD
Flunisolide—CYP3A4—Etoposide—hematologic cancer	0.0013	0.00678	CbGbCtD
Flunisolide—CYP3A4—Dexamethasone—hematologic cancer	0.00107	0.00557	CbGbCtD
Flunisolide—CYP3A4—Doxorubicin—hematologic cancer	0.000886	0.00462	CbGbCtD
Flunisolide—SERPINA6—hematopoietic system—hematologic cancer	0.000189	0.184	CbGeAlD
Flunisolide—SERPINA6—blood—hematologic cancer	0.000125	0.122	CbGeAlD
Flunisolide—SERPINA6—bone marrow—hematologic cancer	0.000121	0.118	CbGeAlD
Flunisolide—SERPINA6—lung—hematologic cancer	0.00011	0.107	CbGeAlD
Flunisolide—NR3C1—hematopoietic system—hematologic cancer	8.29e-05	0.0804	CbGeAlD
Flunisolide—Difluprednate—NR3C1—hematologic cancer	7.39e-05	0.0471	CrCbGaD
Flunisolide—Clocortolone—NR3C1—hematologic cancer	7.17e-05	0.0456	CrCbGaD
Flunisolide—Prednicarbate—NR3C1—hematologic cancer	7.17e-05	0.0456	CrCbGaD
Flunisolide—Desonide—NR3C1—hematologic cancer	6.78e-05	0.0432	CrCbGaD
Flunisolide—Diflorasone—NR3C1—hematologic cancer	6.78e-05	0.0432	CrCbGaD
Flunisolide—Desoximetasone—NR3C1—hematologic cancer	6.61e-05	0.0421	CrCbGaD
Flunisolide—Loteprednol—NR3C1—hematologic cancer	6.53e-05	0.0416	CrCbGaD
Flunisolide—NR3C1—gonad—hematologic cancer	6.3e-05	0.0612	CbGeAlD
Flunisolide—CYP3A4—hematopoietic system—hematologic cancer	6.27e-05	0.0608	CbGeAlD
Flunisolide—Flurandrenolide—NR3C1—hematologic cancer	5.79e-05	0.0369	CrCbGaD
Flunisolide—Flumethasone Pivalate—NR3C1—hematologic cancer	5.69e-05	0.0363	CrCbGaD
Flunisolide—Halobetasol Propionate—NR3C1—hematologic cancer	5.6e-05	0.0357	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—NCOR2—hematologic cancer	5.59e-05	0.00331	CbGpPWpGaD
Flunisolide—NR3C1—blood—hematologic cancer	5.49e-05	0.0533	CbGeAlD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	5.48e-05	0.00325	CbGpPWpGaD
Flunisolide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	5.47e-05	0.00324	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	5.47e-05	0.00324	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	5.46e-05	0.00324	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	5.43e-05	0.00322	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	5.35e-05	0.00317	CbGpPWpGaD
Flunisolide—NR3C1—bone marrow—hematologic cancer	5.32e-05	0.0516	CbGeAlD
Flunisolide—Budesonide—NR3C1—hematologic cancer	5.21e-05	0.0332	CrCbGaD
Flunisolide—Amcinonide—NR3C1—hematologic cancer	5.21e-05	0.0332	CrCbGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	5.2e-05	0.00308	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	5.18e-05	0.00307	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—NCOR1—hematologic cancer	5.18e-05	0.00307	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	5.17e-05	0.00306	CbGpPWpGaD
Flunisolide—Fluticasone furoate—NR3C1—hematologic cancer	5.11e-05	0.0325	CrCbGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	5.1e-05	0.00302	CbGpPWpGaD
Flunisolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	5.09e-05	0.00302	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	5.03e-05	0.00298	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	5.01e-05	0.00297	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	4.96e-05	0.00294	CbGpPWpGaD
Flunisolide—Mometasone—NR3C1—hematologic cancer	4.95e-05	0.0315	CrCbGaD
Flunisolide—Rimexolone—NR3C1—hematologic cancer	4.9e-05	0.0312	CrCbGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	4.89e-05	0.0029	CbGpPWpGaD
Flunisolide—NR3C1—lung—hematologic cancer	4.82e-05	0.0467	CbGeAlD
Flunisolide—Fluocinonide—NR3C1—hematologic cancer	4.62e-05	0.0294	CrCbGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	4.61e-05	0.00273	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	4.55e-05	0.0027	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—STAT5B—hematologic cancer	4.55e-05	0.00269	CbGpPWpGaD
Flunisolide—NR3C1—testis—hematologic cancer	4.54e-05	0.0441	CbGeAlD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	4.52e-05	0.00268	CbGpPWpGaD
Flunisolide—Fluocinolone Acetonide—NR3C1—hematologic cancer	4.49e-05	0.0286	CrCbGaD
Flunisolide—Alclometasone—NR3C1—hematologic cancer	4.49e-05	0.0286	CrCbGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	4.45e-05	0.00264	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	4.41e-05	0.00261	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	4.37e-05	0.00259	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	4.36e-05	0.00259	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	4.35e-05	0.00257	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	4.32e-05	0.00256	CbGpPWpGaD
Flunisolide—Paramethasone—NR3C1—hematologic cancer	4.31e-05	0.0275	CrCbGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	4.27e-05	0.00253	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	4.27e-05	0.00253	CbGpPWpGaD
Flunisolide—Ciclesonide—NR3C1—hematologic cancer	4.24e-05	0.027	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	4.22e-05	0.0025	CbGpPWpGaD
Flunisolide—Fluorometholone—NR3C1—hematologic cancer	4.21e-05	0.0268	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	4.2e-05	0.00249	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	4.19e-05	0.00248	CbGpPWpGaD
Flunisolide—CYP3A4—blood—hematologic cancer	4.15e-05	0.0403	CbGeAlD
Flunisolide—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	4.15e-05	0.00246	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	4.1e-05	0.00243	CbGpPWpGaD
Flunisolide—Methylprednisolone—NR3C1—hematologic cancer	4.07e-05	0.0259	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	4e-05	0.00237	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	4e-05	0.00237	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	3.99e-05	0.00236	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	3.93e-05	0.00233	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	3.8e-05	0.00225	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	3.8e-05	0.00225	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	3.76e-05	0.00223	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—GATA3—hematologic cancer	3.75e-05	0.00222	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	3.72e-05	0.0022	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	3.7e-05	0.00219	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	3.67e-05	0.00218	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	3.66e-05	0.00217	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—CREB1—hematologic cancer	3.66e-05	0.00217	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	3.66e-05	0.00217	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	3.59e-05	0.00213	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—CREBBP—hematologic cancer	3.56e-05	0.00211	CbGpPWpGaD
Flunisolide—Triamcinolone—NR3C1—hematologic cancer	3.43e-05	0.0219	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	3.35e-05	0.00199	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	3.33e-05	0.00197	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	3.32e-05	0.00197	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	3.31e-05	0.00196	CbGpPWpGaD
Flunisolide—NR3C1—lymph node—hematologic cancer	3.29e-05	0.0319	CbGeAlD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	3.24e-05	0.00192	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	3.24e-05	0.00192	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	3.17e-05	0.00188	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	3.12e-05	0.00185	CbGpPWpGaD
Flunisolide—Prednisone—NR3C1—hematologic cancer	3.11e-05	0.0198	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—STAT1—hematologic cancer	3.08e-05	0.00182	CbGpPWpGaD
Flunisolide—Fluticasone Propionate—NR3C1—hematologic cancer	3.07e-05	0.0195	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	3.02e-05	0.00179	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	3.02e-05	0.00179	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	3.01e-05	0.00178	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	3e-05	0.00178	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	2.98e-05	0.00177	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	2.95e-05	0.00175	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ZNF552—hematologic cancer	2.94e-05	0.00174	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	2.91e-05	0.00172	CbGpPWpGaD
Flunisolide—Prednisolone—NR3C1—hematologic cancer	2.87e-05	0.0183	CrCbGaD
Flunisolide—Betamethasone—NR3C1—hematologic cancer	2.81e-05	0.0179	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—STAT5A—hematologic cancer	2.77e-05	0.00164	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	2.72e-05	0.00161	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	2.71e-05	0.00161	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	2.69e-05	0.00159	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	2.68e-05	0.00159	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	2.66e-05	0.00158	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	2.66e-05	0.00158	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	2.61e-05	0.00155	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—NCOR1—hematologic cancer	2.6e-05	0.00154	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	2.59e-05	0.00154	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	2.59e-05	0.00153	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	2.58e-05	0.00153	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	2.57e-05	0.00152	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	2.57e-05	0.00152	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	2.56e-05	0.00152	CbGpPWpGaD
Flunisolide—Hydrocortisone—ABCG2—hematologic cancer	2.54e-05	0.0162	CrCbGaD
Flunisolide—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.53e-05	0.0015	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.51e-05	0.00149	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.5e-05	0.00148	CbGpPWpGaD
Flunisolide—Fluticasone furoate—ABCB1—hematologic cancer	2.46e-05	0.0157	CrCbGaD
Flunisolide—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	2.43e-05	0.00144	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	2.43e-05	0.00144	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—EP300—hematologic cancer	2.43e-05	0.00144	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—FAS—hematologic cancer	2.33e-05	0.00138	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	2.28e-05	0.00135	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	2.26e-05	0.00134	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	2.26e-05	0.00134	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.25e-05	0.00133	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.23e-05	0.00132	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CASC3—hematologic cancer	2.23e-05	0.00132	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.21e-05	0.00131	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.2e-05	0.0013	CbGpPWpGaD
Flunisolide—Hydrocortisone—NR3C1—hematologic cancer	2.19e-05	0.014	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.17e-05	0.00129	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.17e-05	0.00129	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	2.16e-05	0.00128	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	2.13e-05	0.00126	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	2.1e-05	0.00124	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	2.04e-05	0.00121	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	2e-05	0.00119	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	1.97e-05	0.00116	CbGpPWpGaD
Flunisolide—Methylprednisolone—ABCB1—hematologic cancer	1.96e-05	0.0125	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	1.93e-05	0.00114	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	1.91e-05	0.00113	CbGpPWpGaD
Flunisolide—Dexamethasone—ABCG2—hematologic cancer	1.9e-05	0.0121	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	1.87e-05	0.00111	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	1.85e-05	0.0011	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—CREB1—hematologic cancer	1.84e-05	0.00109	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	1.81e-05	0.00107	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—RB1—hematologic cancer	1.78e-05	0.00106	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.78e-05	0.00106	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.78e-05	0.00106	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.76e-05	0.00104	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.75e-05	0.00104	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.74e-05	0.00103	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.74e-05	0.00103	CbGpPWpGaD
Flunisolide—Dexamethasone—NR3C1—hematologic cancer	1.64e-05	0.0104	CrCbGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.59e-05	0.000942	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.58e-05	0.000936	CbGpPWpGaD
Flunisolide—Prednisone—ALB—hematologic cancer	1.57e-05	0.01	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.55e-05	0.00092	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.55e-05	0.000919	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.55e-05	0.000917	CbGpPWpGaD
Flunisolide—Prednisone—ABCB1—hematologic cancer	1.5e-05	0.00957	CrCbGaD
Flunisolide—NR3C1—Gene Expression—RARS—hematologic cancer	1.44e-05	0.000851	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.43e-05	0.000849	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	1.39e-05	0.000826	CbGpPWpGaD
Flunisolide—Prednisolone—ABCB1—hematologic cancer	1.38e-05	0.00882	CrCbGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	1.37e-05	0.000814	CbGpPWpGaD
Flunisolide—Betamethasone—ABCB1—hematologic cancer	1.36e-05	0.00864	CrCbGaD
Flunisolide—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.35e-05	0.000801	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.31e-05	0.000777	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	1.31e-05	0.000776	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.3e-05	0.00077	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.29e-05	0.000766	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.28e-05	0.00076	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.26e-05	0.000748	CbGpPWpGaD
Flunisolide—Rash—Irinotecan—hematologic cancer	1.26e-05	0.000166	CcSEcCtD
Flunisolide—Dermatitis—Irinotecan—hematologic cancer	1.25e-05	0.000166	CcSEcCtD
Flunisolide—Dermatitis—Mitoxantrone—hematologic cancer	1.25e-05	0.000166	CcSEcCtD
Flunisolide—Chills—Methotrexate—hematologic cancer	1.25e-05	0.000165	CcSEcCtD
Flunisolide—Headache—Irinotecan—hematologic cancer	1.25e-05	0.000165	CcSEcCtD
Flunisolide—Headache—Mitoxantrone—hematologic cancer	1.25e-05	0.000165	CcSEcCtD
Flunisolide—Nausea—Ifosfamide—hematologic cancer	1.25e-05	0.000165	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.24e-05	0.000164	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.24e-05	0.000164	CcSEcCtD
Flunisolide—Myalgia—Prednisone—hematologic cancer	1.24e-05	0.000164	CcSEcCtD
Flunisolide—Feeling abnormal—Triamcinolone—hematologic cancer	1.24e-05	0.000164	CcSEcCtD
Flunisolide—Diarrhoea—Cisplatin—hematologic cancer	1.24e-05	0.000163	CcSEcCtD
Flunisolide—Erythema multiforme—Epirubicin—hematologic cancer	1.24e-05	0.000163	CcSEcCtD
Flunisolide—Anxiety—Prednisone—hematologic cancer	1.23e-05	0.000163	CcSEcCtD
Flunisolide—Vomiting—Gemcitabine—hematologic cancer	1.23e-05	0.000163	CcSEcCtD
Flunisolide—Insomnia—Betamethasone—hematologic cancer	1.23e-05	0.000163	CcSEcCtD
Flunisolide—Insomnia—Dexamethasone—hematologic cancer	1.23e-05	0.000163	CcSEcCtD
Flunisolide—Discomfort—Prednisone—hematologic cancer	1.22e-05	0.000162	CcSEcCtD
Flunisolide—Rash—Gemcitabine—hematologic cancer	1.22e-05	0.000162	CcSEcCtD
Flunisolide—Dermatitis—Gemcitabine—hematologic cancer	1.22e-05	0.000161	CcSEcCtD
Flunisolide—Hypersensitivity—Etoposide—hematologic cancer	1.22e-05	0.000161	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—hematologic cancer	1.22e-05	0.000161	CcSEcCtD
Flunisolide—Headache—Gemcitabine—hematologic cancer	1.22e-05	0.00016	CcSEcCtD
Flunisolide—Nausea—Vincristine—hematologic cancer	1.21e-05	0.00016	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—hematologic cancer	1.21e-05	0.00016	CcSEcCtD
Flunisolide—Hypersensitivity—Prednisolone—hematologic cancer	1.2e-05	0.000159	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—hematologic cancer	1.2e-05	0.000159	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—hematologic cancer	1.2e-05	0.000159	CcSEcCtD
Flunisolide—Dyspepsia—Betamethasone—hematologic cancer	1.2e-05	0.000158	CcSEcCtD
Flunisolide—Dyspepsia—Dexamethasone—hematologic cancer	1.2e-05	0.000158	CcSEcCtD
Flunisolide—Urticaria—Triamcinolone—hematologic cancer	1.19e-05	0.000158	CcSEcCtD
Flunisolide—Oedema peripheral—Doxorubicin—hematologic cancer	1.19e-05	0.000157	CcSEcCtD
Flunisolide—Dysgeusia—Methotrexate—hematologic cancer	1.19e-05	0.000157	CcSEcCtD
Flunisolide—Asthenia—Etoposide—hematologic cancer	1.19e-05	0.000157	CcSEcCtD
Flunisolide—Body temperature increased—Triamcinolone—hematologic cancer	1.19e-05	0.000157	CcSEcCtD
Flunisolide—Oedema—Prednisone—hematologic cancer	1.19e-05	0.000157	CcSEcCtD
Flunisolide—Decreased appetite—Dexamethasone—hematologic cancer	1.19e-05	0.000157	CcSEcCtD
Flunisolide—Decreased appetite—Betamethasone—hematologic cancer	1.19e-05	0.000157	CcSEcCtD
Flunisolide—Nausea—Irinotecan—hematologic cancer	1.18e-05	0.000156	CcSEcCtD
Flunisolide—Nausea—Mitoxantrone—hematologic cancer	1.18e-05	0.000156	CcSEcCtD
Flunisolide—Infection—Prednisone—hematologic cancer	1.18e-05	0.000156	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.18e-05	0.000699	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.18e-05	0.000697	CbGpPWpGaD
Flunisolide—Back pain—Methotrexate—hematologic cancer	1.18e-05	0.000155	CcSEcCtD
Flunisolide—Fatigue—Betamethasone—hematologic cancer	1.18e-05	0.000155	CcSEcCtD
Flunisolide—Fatigue—Dexamethasone—hematologic cancer	1.18e-05	0.000155	CcSEcCtD
Flunisolide—Chills—Epirubicin—hematologic cancer	1.17e-05	0.000155	CcSEcCtD
Flunisolide—Pruritus—Etoposide—hematologic cancer	1.17e-05	0.000155	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—TET2—hematologic cancer	1.17e-05	0.000694	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RARA—hematologic cancer	1.17e-05	0.000694	CbGpPWpGaD
Flunisolide—Shock—Prednisone—hematologic cancer	1.17e-05	0.000154	CcSEcCtD
Flunisolide—Pain—Dexamethasone—hematologic cancer	1.17e-05	0.000154	CcSEcCtD
Flunisolide—Pain—Betamethasone—hematologic cancer	1.17e-05	0.000154	CcSEcCtD
Flunisolide—Tachycardia—Prednisone—hematologic cancer	1.16e-05	0.000153	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.16e-05	0.000685	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.16e-05	0.000684	CbGpPWpGaD
Flunisolide—Nausea—Gemcitabine—hematologic cancer	1.15e-05	0.000152	CcSEcCtD
Flunisolide—Vomiting—Cisplatin—hematologic cancer	1.15e-05	0.000152	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.15e-05	0.000681	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Prednisone—hematologic cancer	1.15e-05	0.000152	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—hematologic cancer	1.15e-05	0.000151	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.14e-05	0.000678	CbGpPWpGaD
Flunisolide—Erythema multiforme—Doxorubicin—hematologic cancer	1.14e-05	0.000151	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.14e-05	0.000677	CbGpPWpGaD
Flunisolide—Rash—Cisplatin—hematologic cancer	1.14e-05	0.000151	CcSEcCtD
Flunisolide—Dermatitis—Cisplatin—hematologic cancer	1.14e-05	0.00015	CcSEcCtD
Flunisolide—Malnutrition—Epirubicin—hematologic cancer	1.14e-05	0.00015	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.14e-05	0.000673	CbGpPWpGaD
Flunisolide—Diarrhoea—Etoposide—hematologic cancer	1.13e-05	0.00015	CcSEcCtD
Flunisolide—Ill-defined disorder—Methotrexate—hematologic cancer	1.13e-05	0.000149	CcSEcCtD
Flunisolide—Feeling abnormal—Dexamethasone—hematologic cancer	1.12e-05	0.000148	CcSEcCtD
Flunisolide—Feeling abnormal—Betamethasone—hematologic cancer	1.12e-05	0.000148	CcSEcCtD
Flunisolide—Gastrointestinal pain—Betamethasone—hematologic cancer	1.12e-05	0.000147	CcSEcCtD
Flunisolide—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.12e-05	0.000147	CcSEcCtD
Flunisolide—Dysgeusia—Epirubicin—hematologic cancer	1.11e-05	0.000147	CcSEcCtD
Flunisolide—Hypersensitivity—Triamcinolone—hematologic cancer	1.11e-05	0.000146	CcSEcCtD
Flunisolide—Back pain—Epirubicin—hematologic cancer	1.1e-05	0.000145	CcSEcCtD
Flunisolide—Malaise—Methotrexate—hematologic cancer	1.1e-05	0.000145	CcSEcCtD
Flunisolide—Dizziness—Etoposide—hematologic cancer	1.1e-05	0.000145	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—hematologic cancer	1.09e-05	0.000144	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.09e-05	0.000645	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.09e-05	0.000644	CbGpPWpGaD
Flunisolide—Chills—Doxorubicin—hematologic cancer	1.09e-05	0.000143	CcSEcCtD
Flunisolide—Urticaria—Dexamethasone—hematologic cancer	1.08e-05	0.000143	CcSEcCtD
Flunisolide—Urticaria—Betamethasone—hematologic cancer	1.08e-05	0.000143	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.08e-05	0.000143	CcSEcCtD
Flunisolide—Dizziness—Prednisolone—hematologic cancer	1.08e-05	0.000143	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.08e-05	0.00064	CbGpPWpGaD
Flunisolide—Asthenia—Triamcinolone—hematologic cancer	1.08e-05	0.000142	CcSEcCtD
Flunisolide—Abdominal pain—Betamethasone—hematologic cancer	1.08e-05	0.000142	CcSEcCtD
Flunisolide—Abdominal pain—Dexamethasone—hematologic cancer	1.08e-05	0.000142	CcSEcCtD
Flunisolide—Body temperature increased—Dexamethasone—hematologic cancer	1.08e-05	0.000142	CcSEcCtD
Flunisolide—Body temperature increased—Betamethasone—hematologic cancer	1.08e-05	0.000142	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.08e-05	0.000638	CbGpPWpGaD
Flunisolide—Nausea—Cisplatin—hematologic cancer	1.07e-05	0.000142	CcSEcCtD
Flunisolide—Insomnia—Prednisone—hematologic cancer	1.07e-05	0.000142	CcSEcCtD
Flunisolide—Vision blurred—Epirubicin—hematologic cancer	1.07e-05	0.000142	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.07e-05	0.000631	CbGpPWpGaD
Flunisolide—Pruritus—Triamcinolone—hematologic cancer	1.06e-05	0.00014	CcSEcCtD
Flunisolide—Cough—Methotrexate—hematologic cancer	1.06e-05	0.00014	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.06e-05	0.000628	CbGpPWpGaD
Flunisolide—Hydrocortisone—ABCB1—hematologic cancer	1.06e-05	0.00675	CrCbGaD
Flunisolide—Ill-defined disorder—Epirubicin—hematologic cancer	1.06e-05	0.000139	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.05e-05	0.000625	CbGpPWpGaD
Flunisolide—Vomiting—Etoposide—hematologic cancer	1.05e-05	0.000139	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—hematologic cancer	1.05e-05	0.000139	CcSEcCtD
Flunisolide—Agitation—Epirubicin—hematologic cancer	1.05e-05	0.000138	CcSEcCtD
Flunisolide—Dyspepsia—Prednisone—hematologic cancer	1.05e-05	0.000138	CcSEcCtD
Flunisolide—Rash—Etoposide—hematologic cancer	1.04e-05	0.000138	CcSEcCtD
Flunisolide—Dermatitis—Etoposide—hematologic cancer	1.04e-05	0.000138	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.04e-05	0.000616	CbGpPWpGaD
Flunisolide—Headache—Etoposide—hematologic cancer	1.04e-05	0.000137	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—hematologic cancer	1.04e-05	0.000137	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—hematologic cancer	1.04e-05	0.000137	CcSEcCtD
Flunisolide—Decreased appetite—Prednisone—hematologic cancer	1.03e-05	0.000136	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—hematologic cancer	1.03e-05	0.000136	CcSEcCtD
Flunisolide—Rash—Prednisolone—hematologic cancer	1.03e-05	0.000136	CcSEcCtD
Flunisolide—Dermatitis—Prednisolone—hematologic cancer	1.03e-05	0.000136	CcSEcCtD
Flunisolide—Malaise—Epirubicin—hematologic cancer	1.03e-05	0.000135	CcSEcCtD
Flunisolide—Fatigue—Prednisone—hematologic cancer	1.02e-05	0.000135	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—ELL—hematologic cancer	1.02e-05	0.000607	CbGpPWpGaD
Flunisolide—Headache—Prednisolone—hematologic cancer	1.02e-05	0.000135	CcSEcCtD
Flunisolide—Discomfort—Methotrexate—hematologic cancer	1.02e-05	0.000135	CcSEcCtD
Flunisolide—Vertigo—Epirubicin—hematologic cancer	1.02e-05	0.000135	CcSEcCtD
Flunisolide—Syncope—Epirubicin—hematologic cancer	1.02e-05	0.000135	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—hematologic cancer	1.02e-05	0.000134	CcSEcCtD
Flunisolide—Constipation—Prednisone—hematologic cancer	1.02e-05	0.000134	CcSEcCtD
Flunisolide—Palpitations—Epirubicin—hematologic cancer	1.01e-05	0.000133	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1e-05	0.000593	CbGpPWpGaD
Flunisolide—Loss of consciousness—Epirubicin—hematologic cancer	1e-05	0.000132	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	9.98e-06	0.000592	CbGpPWpGaD
Flunisolide—Dizziness—Triamcinolone—hematologic cancer	9.94e-06	0.000131	CcSEcCtD
Flunisolide—Cough—Epirubicin—hematologic cancer	9.93e-06	0.000131	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—hematologic cancer	9.92e-06	0.000131	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—TNF—hematologic cancer	9.9e-06	0.000587	CbGpPWpGaD
Flunisolide—Infection—Methotrexate—hematologic cancer	9.86e-06	0.00013	CcSEcCtD
Flunisolide—Nausea—Etoposide—hematologic cancer	9.84e-06	0.00013	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—NCOR2—hematologic cancer	9.83e-06	0.000582	CbGpPWpGaD
Flunisolide—Hypertension—Epirubicin—hematologic cancer	9.83e-06	0.00013	CcSEcCtD
Flunisolide—Feeling abnormal—Prednisone—hematologic cancer	9.79e-06	0.000129	CcSEcCtD
Flunisolide—Asthenia—Betamethasone—hematologic cancer	9.78e-06	0.000129	CcSEcCtD
Flunisolide—Asthenia—Dexamethasone—hematologic cancer	9.78e-06	0.000129	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—hematologic cancer	9.77e-06	0.000129	CcSEcCtD
Flunisolide—Gastrointestinal pain—Prednisone—hematologic cancer	9.71e-06	0.000128	CcSEcCtD
Flunisolide—Nausea—Prednisolone—hematologic cancer	9.71e-06	0.000128	CcSEcCtD
Flunisolide—Myalgia—Epirubicin—hematologic cancer	9.69e-06	0.000128	CcSEcCtD
Flunisolide—Chest pain—Epirubicin—hematologic cancer	9.69e-06	0.000128	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—hematologic cancer	9.68e-06	0.000128	CcSEcCtD
Flunisolide—Anxiety—Epirubicin—hematologic cancer	9.66e-06	0.000127	CcSEcCtD
Flunisolide—Pruritus—Betamethasone—hematologic cancer	9.65e-06	0.000127	CcSEcCtD
Flunisolide—Pruritus—Dexamethasone—hematologic cancer	9.65e-06	0.000127	CcSEcCtD
Flunisolide—Hyperhidrosis—Methotrexate—hematologic cancer	9.59e-06	0.000127	CcSEcCtD
Flunisolide—Discomfort—Epirubicin—hematologic cancer	9.57e-06	0.000126	CcSEcCtD
Flunisolide—Vomiting—Triamcinolone—hematologic cancer	9.56e-06	0.000126	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	9.5e-06	0.000563	CbGpPWpGaD
Flunisolide—Malaise—Doxorubicin—hematologic cancer	9.5e-06	0.000125	CcSEcCtD
Flunisolide—Rash—Triamcinolone—hematologic cancer	9.48e-06	0.000125	CcSEcCtD
Flunisolide—Dermatitis—Triamcinolone—hematologic cancer	9.47e-06	0.000125	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—hematologic cancer	9.46e-06	0.000125	CcSEcCtD
Flunisolide—Syncope—Doxorubicin—hematologic cancer	9.44e-06	0.000125	CcSEcCtD
Flunisolide—Urticaria—Prednisone—hematologic cancer	9.43e-06	0.000125	CcSEcCtD
Flunisolide—Headache—Triamcinolone—hematologic cancer	9.41e-06	0.000124	CcSEcCtD
Flunisolide—Abdominal pain—Prednisone—hematologic cancer	9.39e-06	0.000124	CcSEcCtD
Flunisolide—Body temperature increased—Prednisone—hematologic cancer	9.39e-06	0.000124	CcSEcCtD
Flunisolide—Diarrhoea—Betamethasone—hematologic cancer	9.33e-06	0.000123	CcSEcCtD
Flunisolide—Diarrhoea—Dexamethasone—hematologic cancer	9.33e-06	0.000123	CcSEcCtD
Flunisolide—Palpitations—Doxorubicin—hematologic cancer	9.31e-06	0.000123	CcSEcCtD
Flunisolide—Oedema—Epirubicin—hematologic cancer	9.29e-06	0.000123	CcSEcCtD
Flunisolide—Loss of consciousness—Doxorubicin—hematologic cancer	9.25e-06	0.000122	CcSEcCtD
Flunisolide—Infection—Epirubicin—hematologic cancer	9.23e-06	0.000122	CcSEcCtD
Flunisolide—Cough—Doxorubicin—hematologic cancer	9.19e-06	0.000121	CcSEcCtD
Flunisolide—Shock—Epirubicin—hematologic cancer	9.14e-06	0.000121	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—hematologic cancer	9.09e-06	0.00012	CcSEcCtD
Flunisolide—Tachycardia—Epirubicin—hematologic cancer	9.06e-06	0.00012	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—AGO2—hematologic cancer	9.06e-06	0.000537	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	9.04e-06	0.000119	CcSEcCtD
Flunisolide—Dizziness—Dexamethasone—hematologic cancer	9.02e-06	0.000119	CcSEcCtD
Flunisolide—Dizziness—Betamethasone—hematologic cancer	9.02e-06	0.000119	CcSEcCtD
Flunisolide—Hyperhidrosis—Epirubicin—hematologic cancer	8.98e-06	0.000119	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—hematologic cancer	8.98e-06	0.000119	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—hematologic cancer	8.96e-06	0.000118	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—hematologic cancer	8.96e-06	0.000118	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—hematologic cancer	8.93e-06	0.000118	CcSEcCtD
Flunisolide—Nausea—Triamcinolone—hematologic cancer	8.93e-06	0.000118	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—H3F3B—hematologic cancer	8.88e-06	0.000526	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—DNMT3B—hematologic cancer	8.88e-06	0.000526	CbGpPWpGaD
Flunisolide—Discomfort—Doxorubicin—hematologic cancer	8.86e-06	0.000117	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—hematologic cancer	8.85e-06	0.000117	CcSEcCtD
Flunisolide—Hypersensitivity—Prednisone—hematologic cancer	8.75e-06	0.000116	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—hematologic cancer	8.74e-06	0.000115	CcSEcCtD
Flunisolide—Vomiting—Betamethasone—hematologic cancer	8.67e-06	0.000114	CcSEcCtD
Flunisolide—Vomiting—Dexamethasone—hematologic cancer	8.67e-06	0.000114	CcSEcCtD
Flunisolide—Decreased appetite—Methotrexate—hematologic cancer	8.63e-06	0.000114	CcSEcCtD
Flunisolide—Rash—Dexamethasone—hematologic cancer	8.6e-06	0.000114	CcSEcCtD
Flunisolide—Rash—Betamethasone—hematologic cancer	8.6e-06	0.000114	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—hematologic cancer	8.59e-06	0.000113	CcSEcCtD
Flunisolide—Dermatitis—Betamethasone—hematologic cancer	8.59e-06	0.000113	CcSEcCtD
Flunisolide—Dermatitis—Dexamethasone—hematologic cancer	8.59e-06	0.000113	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—hematologic cancer	8.56e-06	0.000113	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	8.56e-06	0.000507	CbGpPWpGaD
Flunisolide—Headache—Betamethasone—hematologic cancer	8.54e-06	0.000113	CcSEcCtD
Flunisolide—Headache—Dexamethasone—hematologic cancer	8.54e-06	0.000113	CcSEcCtD
Flunisolide—Infection—Doxorubicin—hematologic cancer	8.54e-06	0.000113	CcSEcCtD
Flunisolide—Asthenia—Prednisone—hematologic cancer	8.52e-06	0.000112	CcSEcCtD
Flunisolide—Pain—Methotrexate—hematologic cancer	8.49e-06	0.000112	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.46e-06	0.000112	CcSEcCtD
Flunisolide—Shock—Doxorubicin—hematologic cancer	8.45e-06	0.000112	CcSEcCtD
Flunisolide—Pruritus—Prednisone—hematologic cancer	8.4e-06	0.000111	CcSEcCtD
Flunisolide—Insomnia—Epirubicin—hematologic cancer	8.4e-06	0.000111	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—hematologic cancer	8.39e-06	0.000111	CcSEcCtD
Flunisolide—Hyperhidrosis—Doxorubicin—hematologic cancer	8.31e-06	0.00011	CcSEcCtD
Flunisolide—Dyspnoea—Epirubicin—hematologic cancer	8.28e-06	0.000109	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—hematologic cancer	8.18e-06	0.000108	CcSEcCtD
Flunisolide—Dyspepsia—Epirubicin—hematologic cancer	8.18e-06	0.000108	CcSEcCtD
Flunisolide—Diarrhoea—Prednisone—hematologic cancer	8.13e-06	0.000107	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—RPS14—hematologic cancer	8.12e-06	0.000481	CbGpPWpGaD
Flunisolide—Gastrointestinal pain—Methotrexate—hematologic cancer	8.12e-06	0.000107	CcSEcCtD
Flunisolide—Nausea—Betamethasone—hematologic cancer	8.1e-06	0.000107	CcSEcCtD
Flunisolide—Nausea—Dexamethasone—hematologic cancer	8.1e-06	0.000107	CcSEcCtD
Flunisolide—Decreased appetite—Epirubicin—hematologic cancer	8.07e-06	0.000107	CcSEcCtD
Flunisolide—Fatigue—Epirubicin—hematologic cancer	8.01e-06	0.000106	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—NUP98—hematologic cancer	7.99e-06	0.000474	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—hematologic cancer	7.99e-06	0.000473	CbGpPWpGaD
Flunisolide—Pain—Epirubicin—hematologic cancer	7.94e-06	0.000105	CcSEcCtD
Flunisolide—Constipation—Epirubicin—hematologic cancer	7.94e-06	0.000105	CcSEcCtD
Flunisolide—Dexamethasone—ABCB1—hematologic cancer	7.89e-06	0.00503	CrCbGaD
Flunisolide—Urticaria—Methotrexate—hematologic cancer	7.88e-06	0.000104	CcSEcCtD
Flunisolide—Dizziness—Prednisone—hematologic cancer	7.85e-06	0.000104	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—hematologic cancer	7.85e-06	0.000104	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—hematologic cancer	7.85e-06	0.000104	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.83e-06	0.000103	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—hematologic cancer	7.77e-06	0.000103	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—NUP214—hematologic cancer	7.7e-06	0.000457	CbGpPWpGaD
Flunisolide—Dyspnoea—Doxorubicin—hematologic cancer	7.66e-06	0.000101	CcSEcCtD
Flunisolide—Feeling abnormal—Epirubicin—hematologic cancer	7.65e-06	0.000101	CcSEcCtD
Flunisolide—Gastrointestinal pain—Epirubicin—hematologic cancer	7.59e-06	0.0001	CcSEcCtD
Flunisolide—Dyspepsia—Doxorubicin—hematologic cancer	7.56e-06	9.99e-05	CcSEcCtD
Flunisolide—Vomiting—Prednisone—hematologic cancer	7.55e-06	9.97e-05	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	7.49e-06	0.000444	CbGpPWpGaD
Flunisolide—Rash—Prednisone—hematologic cancer	7.49e-06	9.89e-05	CcSEcCtD
Flunisolide—Dermatitis—Prednisone—hematologic cancer	7.48e-06	9.88e-05	CcSEcCtD
Flunisolide—Decreased appetite—Doxorubicin—hematologic cancer	7.47e-06	9.86e-05	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	7.46e-06	0.000442	CbGpPWpGaD
Flunisolide—Headache—Prednisone—hematologic cancer	7.44e-06	9.82e-05	CcSEcCtD
Flunisolide—Fatigue—Doxorubicin—hematologic cancer	7.41e-06	9.78e-05	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	7.39e-06	0.000438	CbGpPWpGaD
Flunisolide—Urticaria—Epirubicin—hematologic cancer	7.38e-06	9.74e-05	CcSEcCtD
Flunisolide—Pain—Doxorubicin—hematologic cancer	7.35e-06	9.7e-05	CcSEcCtD
Flunisolide—Constipation—Doxorubicin—hematologic cancer	7.35e-06	9.7e-05	CcSEcCtD
Flunisolide—Abdominal pain—Epirubicin—hematologic cancer	7.34e-06	9.69e-05	CcSEcCtD
Flunisolide—Body temperature increased—Epirubicin—hematologic cancer	7.34e-06	9.69e-05	CcSEcCtD
Flunisolide—Hypersensitivity—Methotrexate—hematologic cancer	7.31e-06	9.65e-05	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	7.21e-06	0.000427	CbGpPWpGaD
Flunisolide—Asthenia—Methotrexate—hematologic cancer	7.12e-06	9.4e-05	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	7.1e-06	0.000421	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HSPB1—hematologic cancer	7.1e-06	0.000421	CbGpPWpGaD
Flunisolide—Feeling abnormal—Doxorubicin—hematologic cancer	7.08e-06	9.35e-05	CcSEcCtD
Flunisolide—Nausea—Prednisone—hematologic cancer	7.05e-06	9.31e-05	CcSEcCtD
Flunisolide—Gastrointestinal pain—Doxorubicin—hematologic cancer	7.03e-06	9.28e-05	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—hematologic cancer	7.02e-06	9.27e-05	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	6.9e-06	0.000409	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	6.88e-06	0.000408	CbGpPWpGaD
Flunisolide—Hypersensitivity—Epirubicin—hematologic cancer	6.84e-06	9.03e-05	CcSEcCtD
Flunisolide—Urticaria—Doxorubicin—hematologic cancer	6.83e-06	9.01e-05	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—SMC1A—hematologic cancer	6.8e-06	0.000403	CbGpPWpGaD
Flunisolide—Abdominal pain—Doxorubicin—hematologic cancer	6.79e-06	8.97e-05	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—hematologic cancer	6.79e-06	8.97e-05	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—hematologic cancer	6.79e-06	8.97e-05	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	6.79e-06	0.000402	CbGpPWpGaD
Flunisolide—Asthenia—Epirubicin—hematologic cancer	6.66e-06	8.8e-05	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—H3F3A—hematologic cancer	6.66e-06	0.000395	CbGpPWpGaD
Flunisolide—Pruritus—Epirubicin—hematologic cancer	6.57e-06	8.68e-05	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—hematologic cancer	6.56e-06	8.67e-05	CcSEcCtD
Flunisolide—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	6.54e-06	0.000387	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—EZH2—hematologic cancer	6.39e-06	0.000379	CbGpPWpGaD
Flunisolide—Diarrhoea—Epirubicin—hematologic cancer	6.35e-06	8.39e-05	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—hematologic cancer	6.33e-06	8.36e-05	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—hematologic cancer	6.31e-06	8.33e-05	CcSEcCtD
Flunisolide—Rash—Methotrexate—hematologic cancer	6.26e-06	8.26e-05	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—PARP1—hematologic cancer	6.25e-06	0.000371	CbGpPWpGaD
Flunisolide—Dermatitis—Methotrexate—hematologic cancer	6.25e-06	8.25e-05	CcSEcCtD
Flunisolide—Headache—Methotrexate—hematologic cancer	6.22e-06	8.21e-05	CcSEcCtD
Flunisolide—Asthenia—Doxorubicin—hematologic cancer	6.17e-06	8.14e-05	CcSEcCtD
Flunisolide—Dizziness—Epirubicin—hematologic cancer	6.14e-06	8.11e-05	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—hematologic cancer	6.08e-06	8.03e-05	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—HDAC2—hematologic cancer	6.03e-06	0.000358	CbGpPWpGaD
Flunisolide—Vomiting—Epirubicin—hematologic cancer	5.91e-06	7.8e-05	CcSEcCtD
Flunisolide—Nausea—Methotrexate—hematologic cancer	5.9e-06	7.78e-05	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—hematologic cancer	5.88e-06	7.76e-05	CcSEcCtD
Flunisolide—Rash—Epirubicin—hematologic cancer	5.86e-06	7.73e-05	CcSEcCtD
Flunisolide—Dermatitis—Epirubicin—hematologic cancer	5.85e-06	7.72e-05	CcSEcCtD
Flunisolide—Headache—Epirubicin—hematologic cancer	5.82e-06	7.68e-05	CcSEcCtD
Flunisolide—CYP3A4—Metabolism—GMPS—hematologic cancer	5.74e-06	0.00034	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—FTCD—hematologic cancer	5.74e-06	0.00034	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PHYH—hematologic cancer	5.74e-06	0.00034	CbGpPWpGaD
Flunisolide—Dizziness—Doxorubicin—hematologic cancer	5.68e-06	7.5e-05	CcSEcCtD
Flunisolide—Nausea—Epirubicin—hematologic cancer	5.52e-06	7.28e-05	CcSEcCtD
Flunisolide—Vomiting—Doxorubicin—hematologic cancer	5.46e-06	7.21e-05	CcSEcCtD
Flunisolide—Rash—Doxorubicin—hematologic cancer	5.42e-06	7.15e-05	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—hematologic cancer	5.41e-06	7.15e-05	CcSEcCtD
Flunisolide—Headache—Doxorubicin—hematologic cancer	5.38e-06	7.11e-05	CcSEcCtD
Flunisolide—CYP3A4—Metabolism—SMPD3—hematologic cancer	5.25e-06	0.000311	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AR—hematologic cancer	5.23e-06	0.00031	CbGpPWpGaD
Flunisolide—Nausea—Doxorubicin—hematologic cancer	5.1e-06	6.74e-05	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—CDKN2B—hematologic cancer	4.82e-06	0.000286	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	4.59e-06	0.000272	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ASNS—hematologic cancer	4.59e-06	0.000272	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—DCK—hematologic cancer	4.59e-06	0.000272	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOR1—hematologic cancer	4.57e-06	0.000271	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HDC—hematologic cancer	4.35e-06	0.000258	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CDA—hematologic cancer	3.98e-06	0.000236	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	3.88e-06	0.00023	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PC—hematologic cancer	3.83e-06	0.000227	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GBA—hematologic cancer	3.7e-06	0.000219	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	3.7e-06	0.000219	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MAPK14—hematologic cancer	3.66e-06	0.000217	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR1—hematologic cancer	3.59e-06	0.000213	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH1—hematologic cancer	3.47e-06	0.000206	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTAP—hematologic cancer	3.38e-06	0.0002	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CREBBP—hematologic cancer	3.15e-06	0.000187	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—FHL2—hematologic cancer	3.01e-06	0.000179	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AGRN—hematologic cancer	2.96e-06	0.000175	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—IDH2—hematologic cancer	2.8e-06	0.000166	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMMR—hematologic cancer	2.8e-06	0.000166	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.63e-06	0.000156	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CA9—hematologic cancer	2.56e-06	0.000152	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ACP5—hematologic cancer	2.56e-06	0.000152	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.53e-06	0.00015	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—IDH1—hematologic cancer	2.41e-06	0.000143	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TXN—hematologic cancer	2.38e-06	0.000141	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.38e-06	0.000141	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.38e-06	0.000141	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.33e-06	0.000138	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.24e-06	0.000133	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.18e-06	0.000129	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.18e-06	0.000129	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.12e-06	0.000126	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NUP98—hematologic cancer	2.06e-06	0.000122	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADCY7—hematologic cancer	2e-06	0.000118	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA3—hematologic cancer	2e-06	0.000118	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NUP214—hematologic cancer	1.98e-06	0.000117	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.94e-06	0.000115	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTR—hematologic cancer	1.94e-06	0.000115	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.92e-06	0.000114	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ENO2—hematologic cancer	1.91e-06	0.000113	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MYC—hematologic cancer	1.87e-06	0.000111	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.85e-06	0.000109	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SDC1—hematologic cancer	1.81e-06	0.000107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CD44—hematologic cancer	1.54e-06	9.1e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NQO1—hematologic cancer	1.54e-06	9.1e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYCS—hematologic cancer	1.45e-06	8.61e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.44e-06	8.56e-05	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AKT1—hematologic cancer	1.3e-06	7.68e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.28e-06	7.59e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.21e-06	7.18e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.18e-06	6.97e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.18e-06	6.97e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.04e-06	6.16e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	8.74e-07	5.18e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.1e-07	4.8e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	7.68e-07	4.55e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALB—hematologic cancer	7.58e-07	4.49e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.25e-07	4.3e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	6.7e-07	3.97e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTEN—hematologic cancer	5.79e-07	3.43e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—EP300—hematologic cancer	5.52e-07	3.27e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.08e-07	2.42e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKT1—hematologic cancer	3.33e-07	1.98e-05	CbGpPWpGaD
